How does dasatinib treat leukemia?

Dasatinib is a targeted drug used to treat chronic myeloid leukemia (CML), especially for patients with Philadelphia chromosome-positive (Ph+) CML who are resistant or intolerant to imatinib mesylate. This drug effectively blocks the BCR-ABL signaling pathway by inhibiting the activity of BCR-ABL tyrosine kinase, thereby inhibiting the proliferation and survival of leukemia cells, thereby achieving the purpose of controlling the disease.

Dasatinib is excellent in treating leukemia. ForCML patients, dasatinib can significantly extend the patient's survival and improve their quality of life. It can not only inhibit the proliferation of cancer cells, but also induce apoptosis of cancer cells, reduce the number of cancer cells in the body, and thereby alleviate the condition. In addition, dasatinib also has strong anti-mutagenic activity, providing an effective alternative treatment option for patients who are resistant or intolerant to other tyrosine kinase inhibitors.

In clinical practice, dasatinib is usually used as a first- or second-line treatment. For newly diagnosed CML patients, if imatinib mesylate treatment is ineffective or the patient cannot tolerate it, doctors may consider using dasatinib. Dasatinib may also become an important treatment option for patients whose disease has progressed despite other treatments.

In addition to treating CML, dasatinib is also used to treat Ph+ patients with acute lymphoblastic leukemia (ALL). In clinical trials, dasatinib combined with other chemotherapy drugs has shown higher response and survival rates.

However, the use of dasatinib may also cause some side effects, such as bone marrow suppression, gastrointestinal reactions, fluid retention, etc. Therefore, during the use of dasatinib, patients need to closely monitor their body's response and follow their doctor's recommendations for medication adjustments.

Overall, dasatinib is an effective and safe drug option in the treatment of leukemia. It can significantly extend patient survival and improve quality of life. However, the specific usage regimen needs to be formulated based on the patient's specific condition and the doctor's advice.